Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The biology and clinical potential of circulating tumor cells
Taja Ložar, Klara Geršak, Maja Čemažar, et al.
Radiology and Oncology (2019) Vol. 53, Iss. 2, pp. 131-147
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Clinical utility of circulating tumor cells: an update
Antoine Vasseur, Nicolas Kiavué, François‐Clément Bidard, et al.
Molecular Oncology (2020) Vol. 15, Iss. 6, pp. 1647-1666
Open Access | Times Cited: 151
Liquid Biopsies, Novel Approaches and Future Directions
Athanasios Armakolas, Maria Kotsari, John Koskinas
Cancers (2023) Vol. 15, Iss. 5, pp. 1579-1579
Open Access | Times Cited: 60
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening
Antonella Sistigu, Martina Musella, Claudia Galassi, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 77
Circulating tumor cells in the early detection of human cancers
Zixin Feng, Junyu Wu, Yuanjun Lu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3251-3265
Open Access | Times Cited: 35
Circulating tumor cells: from new biological insights to clinical practice
Xuyu Gu, Shiyou Wei, Xin Lv
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Critical steps to tumor metastasis: alterations of tumor microenvironment and extracellular matrix in the formation of pre-metastatic and metastatic niche
Jianan Zhuyan, Mingyu Chen, Tianhao Zhu, et al.
Cell & Bioscience (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 54
Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring
X. Tao, Qianqian Li, Yong Zeng
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
The Epigenetic landscape of Circulating tumour cells
Sai Shyam Vasantharajan, Michael R. Eccles, Euan J. Rodger, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188514-188514
Closed Access | Times Cited: 32
Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility
József Petrik, Donatella Verbanac, Marija Fabijanec, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13582-13582
Open Access | Times Cited: 22
Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells
Amalia Kotsifaki, Sousanna Maroulaki, Athanasios Armakolas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4832-4832
Open Access | Times Cited: 3
Tumor Hypoxia and Circulating Tumor Cells
Walter Tinganelli, Marco Durante
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9592-9592
Open Access | Times Cited: 27
Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer - preliminary findings
Milena Pązik, Katarzyna Michalska, Marta Żebrowska, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study
Yang Gao, Wan-Hung Fan, Zhengbo Song, et al.
PeerJ (2021) Vol. 9, pp. e10777-e10777
Open Access | Times Cited: 23
Dynamic Monitoring of EMT in CTCs as an Indicator of Cancer Metastasis
Zhen Zhang, Alain Wuethrich, Jing Wang, et al.
Analytical Chemistry (2021) Vol. 93, Iss. 50, pp. 16787-16795
Closed Access | Times Cited: 23
Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management
Daniel Schreyer, John P. Neoptolemos, Simon T. Barry, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 16
Circulating tumor cells as a predictor for poor prognostic factors and overall survival in treatment naïve oral squamous cell carcinoma patients
Burhanuddin Qayyumi, Atul Bharde, Gourishankar Aland, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2022) Vol. 134, Iss. 1, pp. 73-83
Closed Access | Times Cited: 15
Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters
Thi Nguyen, Po-Shuan Huang, Po-Yu Chu, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5372-5372
Open Access | Times Cited: 8
The Evolution of Affordable Technologies in Liquid Biopsy Diagnostics: The Key to Clinical Implementation
George Alexandrou, Katerina-Theresa Mantikas, Rebecca C. Allsopp, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5434-5434
Open Access | Times Cited: 8
Lipocalin-2 promotes breast cancer brain metastasis by enhancing tumor invasion and modulating brain microenvironment
Yang Zhao, Xiaogen Tang, Tingting Lei, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology
Athina A. Kyriazi, Efstathios Papiris, Konstantinos Kitsos Kalyvianakis, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6658-6658
Open Access | Times Cited: 25
Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal
Alexios‐Fotios A. Mentis, Petros Grivas, Efthimios Dardiotis, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 18, pp. 3671-3690
Open Access | Times Cited: 23
An efficient fluorescence in situ hybridization (FISH)-based circulating genetically abnormal cells (CACs) identification method based on Multi-scale MobileNet-YOLO-V4
Chao Xu, Yi Zhang, Xianjun Fan, et al.
Quantitative Imaging in Medicine and Surgery (2022) Vol. 12, Iss. 5, pp. 2961-2976
Open Access | Times Cited: 14
Circulating tumour cell enumeration, biomarker analyses, and kinetics in patients with colorectal cancer and other GI malignancies
Walla Malkawi, Areeb Lutfi, Maaz Khan Afghan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets
Eunice Dotse, King Hoo Lim, Meijun Wang, et al.
Life (2022) Vol. 12, Iss. 2, pp. 323-323
Open Access | Times Cited: 11
Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer
Karolina Buszka, Aliki Ntzifa, Barbara Owecka, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2871-2871
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top